Boyne Capital-backedinfusion provider Infusion Associates is coming to market, sources familiar tell Axios.
Why it matters: As care continues to shift away from hospitals, the $100 billion-plus infusion therapy market is projected to balloon at 8.6% CAGR through 2025, per a 2023 Harris Williams report.
